Discounted Cash Flow Rating
Strong Sell
Return on Equity Rating
Sell
Debt to Equity Rating
Neutral
Price to Earnings Rating
Buy
Analyst Rating
Sell
Simple Moving Average
Neutral
Exponential Moving Average
Neutral
Relative Strength Index
Buy
Standard Deviation
Sell
Williams %R
Strong Buy
Average Directional Index
Neutral
Insider Trading
Strong Buy
Wall Street Data Solutions Rating
Neutral
B
Spero Therapeutics, Inc. Common Stock (SPRO)
Pharmaceutical Preparations
https://www.sperotherapeutics.com
Spero Therapeutics Inc is a clinical-stage biopharmaceutical firm. It focuses on identifying, developing and commercializing novel treatments for MDR (Multi-drug-resistant) bacterial infections and rare diseases. The company's product candidate, tebipenem pivoxil hydrobromide or tebipenem HBr, is designed to be an oral carbapenem-class antibiotic for use in adults to treat MDR Gram-negative infections. It is also developing SPR720, a novel oral antibiotic designed for the treatment of a rare, orphan disease caused by pulmonary non-tuberculous mycobacterial infections, or NTM disease. Besides, it is also focused on SPR206, a next-generation polymyxin investigational product candidate, being developed as an IV-administered medicine to treat MDR Gram-negative infections in the hospital.
675 MASSACHUSETTS AVENUE, 14TH FLOOR
CAMBRIDGE, MA
Current Price
---.--
% Change Today
0.00%
Change Amt. Today
0.00
Active Status
Active
Listing Date
11/02/2017
Market Cap
64,318,429
Shares Outstanding
53,000,000
Weighted SO
52,999,317
Total Employees
N/A
Upcoming Earnings
08/08/2024
Similar Tickers
Beta
0.6330
Last Div
0.0000
Range
0.99-1.89
Chg
-0.0200
Avg Vol
135891
Mkt Cap
64318429
Exch
NASDAQ
Country
US
Phone
857 242 1600
DCF Diff
2.5002
DCF
-0.7152
Div Yield
0.0000
P/S
0.5982
EV Multiple
1.2305
P/FV
0.7976
Div Yield %
0.0000
P/E
3.6786
PEG
0.0275
Payout
0.0000
Current Ratio
2.6783
Quick Ratio
2.6783
Cash Ratio
1.3921
DSO
188.3881
DIO
0.0000
Op Cycle
188.3881
DPO
-200.2116
CCC
388.5997
Gross Margin
1.0457
Op Margin
0.0429
Pretax Margin
0.1865
Net Margin
0.1623
Eff Tax Rate
-0.0955
ROA
0.1165
ROE
0.2070
ROCE
0.0443
NI/EBT
0.8704
EBT/EBIT
4.3445
EBIT/Rev
0.0429
Debt Ratio
0.0329
D/E
0.0613
LT Debt/Cap
0.0383
Total Debt/Cap
0.0578
Int Coverage
4.8033
CF/Debt
-2.9129
Equity Multi
1.8619
Rec Turnover
1.9375
Pay Turnover
-1.8231
Inv Turnover
0.0000
FA Turnover
29.5063
Asset Turnover
0.7174
OCF/Share
-0.2666
FCF/Share
-0.2666
Cash/Share
1.1773
OCF/Sales
-0.1338
FCF/OCF
1.0000
CF Coverage
-2.9129
ST Coverage
-8.3048
CapEx Coverage
0.0000
Div&CapEx Cov
0.0000
P/BV
0.7976
P/B
0.7976
P/S
0.5982
P/E
3.6786
P/FCF
-4.4715
P/OCF
-4.4640
P/CF
-4.4640
PEG
0.0275
P/S
0.5982
EV Multiple
1.2305
P/FV
0.7976
DPS
0.0000
Latest Headlines (EST)
No Headlines Found
Revenue Product Segmentation
Dividend History
Cash Value | Ex-Dividend Date | Declaration Date | Record Date | Pay Date |
---|---|---|---|---|
0.02 | 09/16/2015 | 08/07/2015 | 09/18/2015 | 10/07/2015 |
0.02 | 06/17/2015 | 05/08/2015 | 06/19/2015 | 07/07/2015 |
0.02 | 03/18/2015 | 03/09/2015 | 03/20/2015 | 04/07/2015 |
0.02 | 12/17/2014 | 11/05/2014 | 12/19/2014 | 01/06/2015 |
0.02 | 09/17/2014 | 08/08/2014 | 09/19/2014 | 10/07/2014 |
0.02 | 06/18/2014 | 05/08/2014 | 06/20/2014 | 07/07/2014 |
0.02 | 03/19/2014 | 03/10/2014 | 03/21/2014 | 04/07/2014 |
0.02 | 12/17/2013 | 11/08/2013 | 12/19/2013 | 01/06/2014 |
0.02 | 09/17/2013 | 08/07/2013 | 09/19/2013 | 10/07/2013 |
0.02 | 06/12/2013 | 05/08/2013 | 06/14/2013 | 07/05/2013 |
0.02 | 03/20/2013 | 03/08/2013 | 03/22/2013 | 04/05/2013 |
0.01 | 12/17/2012 | 11/07/2012 | 11/30/-0001 | 01/07/2013 |
0.01 | 09/17/2012 | 08/08/2012 | 11/30/-0001 | 10/05/2012 |
0.01 | 06/13/2012 | 05/10/2012 | 11/30/-0001 | 07/06/2012 |
0.01 | 03/20/2012 | 03/12/2012 | 11/30/-0001 | 04/04/2012 |
0.01 | 12/12/2011 | 11/09/2011 | 11/30/-0001 | 01/05/2012 |
0.01 | 09/14/2011 | 08/10/2011 | 11/30/-0001 | 10/05/2011 |
0.01 | 06/13/2011 | 05/11/2011 | 11/30/-0001 | 07/08/2011 |
0.01 | 03/22/2011 | 03/11/2011 | 11/30/-0001 | 04/04/2011 |
0.01 | 12/13/2010 | 11/10/2010 | 11/30/-0001 | 12/31/2010 |
0.01 | 09/29/2010 | 08/12/2010 | 11/30/-0001 | 10/11/2010 |
0.01 | 06/29/2010 | 05/14/2010 | 11/30/-0001 | 07/12/2010 |
0.01 | 03/30/2010 | 03/10/2010 | 11/30/-0001 | 04/11/2010 |
Year | Purchases | Sales | Total Bought | Total Sold |
---|
Transaction Date | Name | Type Of Owner | Price | Securities Owned | Securities Transacted | Security Name | Transaction Type |
---|
Less Than 3 Months
160.00K Shares Bought (100.00 %)
0.00 Shares Sold (0.00%)
3 - 6 Months
1.55M Shares Bought (87.12 %)
229.74K Shares Sold (12.88%)
6 - 9 Months
460.00K Shares Bought (100.00 %)
0.00 Shares Sold (0.00%)
9 - 12 Months
266.00K Shares Bought (82.03 %)
58.26K Shares Sold (17.97 %)
Investor Name | Investment Discretion | Type of Security | Shares Owned | Avg Price Paid | Market Value | Change In Market Value | Change In Market Value (%) | Ownership | Weight |
---|
Date | Investors Holding | Closed Positions | Increased Positions | Reduced Positions | New Positions | Total Invested | Put/Call Ratio | Total Calls | Total Puts |
---|
Owner | Shares Owned |
---|
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Revenue | 1.69M | ▼ 696.00K | ▲ 1.91M | ▲ 2.74M | ▲ 46.30M | ▲ 71.83M | ▼ 4.20M |
Cost Of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 361.00K | ▼ 38.00K | ▼ -5.06M |
Gross Profit | 1.69M | ▼ 696.00K | ▲ 1.91M | ▲ 2.74M | ▲ 45.94M | ▲ 71.79M | ▼ 9.27M |
Gross Profit Ratio | 1.00 | 1.00 | 1.00 | 1.00 | ▼ 0.99 | ▲ 1.00 | ▲ 2.20 |
Research And Development Expenses | 9.13M | ▲ 25.73M | ▼ 13.21M | ▲ 17.23M | ▼ 15.09M | ▲ 16.52M | ▲ 17.33M |
General And Administrative Expenses | 3.65M | ▲ 3.79M | ▲ 7.50M | ▲ 13.02M | ▼ 6.50M | ▼ 6.43M | ▼ 5.92M |
Selling And Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Selling General And Administrative Expenses | 3.65M | ▲ 3.79M | ▲ 7.50M | ▲ 13.02M | ▼ 6.50M | ▼ 6.43M | ▼ 5.92M |
Other Expenses | 485.00K | ▲ 674.00K | ▼ 211.00K | ▼ -78.00K | ▼ -1.09M | ▲ 3.00K | ▼ -14.00K |
Operating Expenses | 11.08M | ▲ 26.58M | ▼ 20.70M | ▲ 30.25M | ▼ 20.50M | ▲ 22.95M | ▲ 23.25M |
Cost And Expenses | 11.08M | ▲ 26.58M | ▼ 20.70M | ▲ 30.25M | ▼ 20.50M | ▲ 22.99M | ▲ 23.25M |
Interest Income | 485.00K | ▼ -66.00K | ▲ 49.00K | ▲ 76.00K | ▲ 715.00K | ▲ 1.04M | ▲ 1.33M |
Interest Expense | 1.14M | ▼ 0.00 | 0.00 | ▲ 1.94M | ▼ 2.40K | ▲ 961.00K | ▼ 0.00 |
Depreciation And Amortization | 139.00K | ▼ -111.00K | ▲ 191.00K | 191.00K | ▼ -134.00K | ▲ 38.00K | ▲ 91.75K |
Ebitda | -11.08M | ▼ -25.88M | ▲ -18.80M | ▼ -27.16M | ▲ 25.79M | ▲ 48.87M | ▼ -19.05M |
Ebitda Ratio | -6.55 | ▼ -37.19 | ▲ -9.86 | ▼ -9.90 | ▲ 0.56 | ▲ 0.68 | ▼ -4.53 |
Operating Income | -11.08M | ▼ -25.88M | ▲ -18.80M | ▼ -27.50M | ▲ 25.92M | ▲ 48.84M | ▼ -19.05M |
Operating Income Ratio | -6.55 | ▼ -37.19 | ▲ -9.86 | ▼ -10.02 | ▲ 0.56 | ▲ 0.68 | ▼ -4.53 |
Total Other Income Expenses Net | 485.00K | ▲ 674.00K | ▼ 211.00K | ▼ 126.00K | ▲ 847.00K | ▲ 2.74M | ▲ 6.38M |
Income Before Tax | -10.60M | ▼ -25.21M | ▲ -18.59M | ▼ -29.24M | ▲ 26.77M | ▲ 51.58M | ▼ -12.67M |
Income Before Tax Ratio | -6.26 | ▼ -36.22 | ▲ -9.75 | ▼ -10.66 | ▲ 0.58 | ▲ 0.72 | ▼ -3.01 |
Income Tax Expense | -139.00K | ▲ 111.00K | ▼ -191.00K | ▲ 1.94M | ▼ 1.98K | ▲ 387.00K | ▼ -91.75K |
Net Income | -10.60M | ▼ -25.21M | ▲ -18.59M | ▼ -29.24M | ▲ 26.77M | ▲ 51.19M | ▼ -12.67M |
Net Income Ratio | -6.26 | ▼ -36.22 | ▲ -9.75 | ▼ -10.66 | ▲ 0.58 | ▲ 0.71 | ▼ -3.01 |
Eps | -0.60 | ▼ -1.32 | ▲ -0.68 | ▼ -0.91 | ▲ 0.55 | ▲ 0.97 | ▼ -0.24 |
Eps Diluted | -0.60 | ▼ -1.32 | ▲ -0.68 | ▼ -0.91 | ▲ 0.55 | ▲ 0.96 | ▼ -0.24 |
Weighted Average Shs Out | 17.74M | ▲ 19.05M | ▲ 27.37M | ▲ 32.13M | ▲ 48.72M | ▲ 53.00M | ▲ 53.52M |
Weighted Average Shs Out Dil | 17.74M | ▲ 19.05M | ▲ 27.37M | ▲ 32.13M | ▲ 48.72M | ▲ 53.11M | ▲ 53.52M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Cash And Cash Equivalents | 34.08M | ▼ 29.73M | ▲ 85.21M | ▲ 112.58M | ▼ 109.11M | ▼ 76.33M | ▲ 82.27M |
Short Term Investments | 81.36M | ▼ 52.32M | ▼ 41.70M | ▼ 33.82M | ▼ 0.00 | 0.00 | 0.00 |
Cash And Short Term Investments | 115.44M | ▼ 82.05M | ▲ 126.91M | ▲ 146.40M | ▼ 109.11M | ▼ 76.33M | ▲ 82.27M |
Net Receivables | 1.30M | ▲ 8.55M | ▼ 6.18M | ▼ 2.64M | ▼ 1.08M | ▲ 50.70M | ▲ 54.22M |
Inventory | -8.78M | ▼ -13.37M | ▲ -12.24M | ▲ 0.00 | ▼ -4.46M | ▲ 1.00 | 1.00 |
Other Current Assets | 7.48M | ▼ 4.82M | ▲ 6.06M | ▲ 8.83M | ▼ 3.38M | ▲ 4.18M | ▼ 3.67M |
Total Current Assets | 115.44M | ▼ 82.05M | ▲ 126.91M | ▲ 157.87M | ▼ 109.11M | ▲ 131.21M | ▲ 140.15M |
Property Plant Equipment Net | 2.89M | ▲ 7.15M | ▲ 8.78M | ▼ 7.56M | ▼ 5.49M | ▼ 4.16M | ▼ 3.90M |
Goodwill | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Goodwill And Intangible Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Long Term Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 46.59M | ▼ 23.21M |
Tax Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Non Current Assets | 10.67M | ▲ 16.91M | ▲ 17.76M | ▼ 5.64M | ▲ 10.20M | ▼ 435.00K | ▼ 434.00K |
Total Non Current Assets | 13.56M | ▲ 24.06M | ▲ 26.55M | ▼ 13.20M | ▲ 15.70M | ▲ 51.18M | ▼ 27.55M |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 1.00 | ▼ 0.00 |
Total Assets | 129.01M | ▼ 106.10M | ▲ 153.45M | ▲ 171.07M | ▼ 124.80M | ▲ 182.39M | ▼ 167.70M |
Account Payables | 3.60M | ▲ 4.15M | ▼ 1.16M | ▼ 1.10M | ▼ 617.00K | ▲ 1.38M | ▲ 3.07M |
Short Term Debt | 0.00 | ▲ 928.00K | ▲ 947.00K | ▲ 1.36M | ▲ 1.69M | ▲ 1.72M | ▲ 1.73M |
Tax Payables | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 387.00K | 387.00K |
Deferred Revenue | 0.00 | ▼ -928.00K | ▼ -947.00K | ▲ 1.86M | ▲ 10.37M | ▲ 27.11M | ▲ 31.26M |
Other Current Liabilities | 8.72M | ▲ 22.52M | ▼ 13.19M | ▲ 14.35M | ▼ 8.97M | ▼ 6.94M | ▼ 5.77M |
Total Current Liabilities | 12.32M | ▲ 26.66M | ▼ 14.34M | ▲ 18.67M | ▲ 21.65M | ▲ 37.15M | ▲ 41.82M |
Long Term Debt | 0.00 | ▲ 4.62M | ▲ 6.89M | ▼ 5.97M | ▼ 4.96M | ▼ 3.83M | ▼ 3.52M |
Deferred Revenue Non Current | 0.00 | 0.00 | 0.00 | ▲ 8.79M | ▲ 22.17M | ▲ 34.43M | ▼ 26.08M |
Deferred Tax Liabilities Non Current | 0.00 | 0.00 | 0.00 | ▲ 802.00K | ▼ 0.00 | 0.00 | ▼ -1.00 |
Other Non Current Liabilities | 833.00K | ▼ 249.00K | ▼ 177.00K | ▲ 48.55M | ▼ 96.00K | ▼ 87.00K | ▼ 38.00K |
Total Non Current Liabilities | 833.00K | ▲ 4.87M | ▲ 7.07M | ▲ 64.11M | ▼ 27.22M | ▲ 38.34M | ▼ 29.63M |
Other Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ▲ 1.00 |
Capital Lease Obligations | 0.00 | ▲ 5.55M | ▲ 7.84M | ▼ 7.34M | ▼ 6.65M | ▼ 3.83M | ▼ 3.52M |
Total Liabilities | 13.15M | ▲ 31.53M | ▼ 21.41M | ▲ 82.78M | ▼ 48.87M | ▲ 75.50M | ▼ 71.45M |
Preferred Stock | 0.00 | 0.00 | ▲ 3.00K | 3.00K | ▼ 0.00 | 0.00 | 0.00 |
Common Stock | 17.00K | ▲ 19.00K | ▲ 29.00K | ▲ 32.00K | ▲ 52.00K | ▲ 53.00K | ▲ 54.00K |
Retained Earnings | -138.50M | ▼ -199.43M | ▼ -277.71M | ▼ -367.46M | ▼ -413.88M | ▲ -391.07M | ▼ -403.74M |
Accumulated Other Comprehensive Income Loss | -28.00K | ▲ 16.00K | ▼ -7.00K | ▲ -2.00K | ▲ 0.00 | 0.00 | 0.00 |
Other Total Stockholders Equity | 254.81M | ▲ 275.50M | ▲ 409.72M | ▲ 455.72M | ▲ 489.76M | ▲ 497.91M | ▲ 499.94M |
Total Stockholders Equity | 115.86M | ▼ 74.57M | ▲ 132.04M | ▼ 88.29M | ▼ 75.93M | ▲ 106.89M | ▼ 96.25M |
Total Equity | 115.86M | ▼ 74.57M | ▲ 132.04M | ▼ 88.29M | ▼ 75.93M | ▲ 106.89M | ▼ 96.25M |
Total Liabilities And Stockholders Equity | 129.01M | ▼ 106.10M | ▲ 153.45M | ▲ 171.07M | ▼ 124.80M | ▲ 182.39M | ▼ 167.70M |
Minority Interest | 355.00K | ▼ 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Total Liabilities And Total Equity | 129.01M | ▼ 106.10M | ▲ 153.45M | ▲ 171.07M | ▼ 124.80M | ▲ 182.39M | ▼ 167.70M |
Total Investments | 81.36M | ▼ 52.32M | ▼ 41.70M | ▼ 33.82M | ▼ 0.00 | ▲ 46.59M | ▼ 23.21M |
Total Debt | 0.00 | ▲ 5.55M | ▲ 7.84M | ▼ 7.34M | ▼ 6.65M | ▼ 5.54M | ▼ 5.24M |
Net Debt | -34.08M | ▲ -24.19M | ▼ -77.37M | ▼ -105.25M | ▲ -102.46M | ▲ -70.79M | ▼ -77.03M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2024 | |
---|---|---|---|---|---|---|---|
Net Income | -10.60M | ▼ -24.99M | ▲ -18.59M | ▼ -29.24M | ▲ 26.77M | ▲ 51.19M | ▼ -12.67M |
Depreciation And Amortization | 139.00K | ▼ -111.00K | ▲ 191.00K | 191.00K | ▼ 129.00K | ▼ 38.00K | ▼ 0.00 |
Deferred Income Tax | 0.00 | ▼ -308.00K | ▲ -70.00K | ▼ -154.00K | ▲ 0.00 | ▼ -354.00K | ▲ 0.00 |
Stock Based Compensation | 769.00K | ▲ 929.00K | ▲ 1.37M | ▲ 2.93M | ▼ 2.50M | ▼ 2.00M | ▲ 2.02M |
Change In Working Capital | -3.63M | ▲ 6.71M | ▼ 526.00K | ▼ -2.84M | ▲ 14.99M | ▼ -70.97M | ▲ 16.33M |
Accounts Receivables | 0.00 | 0.00 | ▼ -686.00K | ▲ 0.00 | ▼ -131.00K | ▲ 1.44M | ▲ 19.86M |
Inventory | 0.00 | 0.00 | ▲ 2.54M | ▼ 0.00 | ▲ 131.00K | ▼ -1.91M | ▲ 0.00 |
Accounts Payables | 2.17M | ▼ 1.61M | ▼ -1.32M | ▼ -2.06M | ▲ -1.97M | ▲ 275.00K | ▲ 1.69M |
Other Working Capital | -5.80M | ▲ 5.10M | ▼ -9.00K | ▼ -775.00K | ▲ 16.96M | ▼ -72.69M | ▲ -5.22M |
Other Non Cash Items | -189.00K | ▲ 400.00K | ▼ 190.00K | ▲ 1.76M | ▼ 93.00K | ▲ 602.00K | ▼ -19.27M |
Net Cash Provided By Operating Activities | -13.51M | ▼ -17.37M | ▲ -16.38M | ▼ -27.35M | ▲ 44.48M | ▼ -17.49M | ▲ 5.94M |
Investments In Property Plant And Equipment | -2.41M | ▲ -129.00K | ▲ -12.00K | ▲ 39.00K | ▼ -129.00K | ▲ 0.00 | 0.00 |
Acquisitions Net | 88.13M | ▼ 0.00 | ▲ 4.00M | ▼ 0.00 | 0.00 | 0.00 | 0.00 |
Purchases Of Investments | -25.75M | ▲ -12.47M | ▼ -41.73M | ▲ -30.31M | ▲ -26.97M | ▲ 0.00 | 0.00 |
Sales Maturities Of Investments | 35.46M | ▼ 8.50M | ▼ 2.00M | ▲ 7.00M | ▲ 60.78M | ▼ 0.00 | 0.00 |
Other Investing Activities | -88.13M | ▲ 0.00 | ▼ -4.00M | ▲ 0.00 | ▲ 258.00K | ▼ 0.00 | 0.00 |
Net Cash Used For Investing Activities | 7.29M | ▼ -4.10M | ▼ -39.74M | ▲ -23.28M | ▲ 33.94M | ▼ 0.00 | 0.00 |
Debt Repayment | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Common Stock Issued | 0.00 | ▲ 5.50M | ▲ 15.10M | ▼ 0.00 | ▲ 14.18M | ▼ 1.00K | ▼ 0.00 |
Common Stock Repurchased | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | -178.00K | ▲ 98.00K | ▲ 988.00K | ▲ 50.35M | ▼ 14.18M | ▼ 1.00K | ▼ 0.00 |
Net Cash Used Provided By Financing Activities | -178.00K | ▲ 5.60M | ▲ 16.09M | ▲ 50.35M | ▼ 14.18M | ▼ 1.00K | ▼ 0.00 |
Effect Of Forex Changes On Cash | 0.00 | 0.00 | 0.00 | 0.00 | ▼ -33.94M | ▲ 0.00 | 0.00 |
Net Change In Cash | -6.40M | ▼ -15.87M | ▼ -40.03M | ▲ -275.00K | ▲ 58.66M | ▼ -17.49M | ▲ 5.94M |
Cash At End Of Period | 34.08M | ▼ 29.73M | ▲ 85.21M | ▲ 112.58M | ▼ 109.11M | ▼ 76.33M | ▲ 82.27M |
Cash At Beginning Of Period | 40.48M | ▲ 45.60M | ▲ 125.24M | ▼ 112.86M | ▼ 50.45M | ▲ 93.83M | ▼ 76.33M |
Operating Cash Flow | -13.51M | ▼ -17.37M | ▲ -16.38M | ▼ -27.35M | ▲ 44.48M | ▼ -17.49M | ▲ 5.94M |
Capital Expenditure | -2.41M | ▲ -129.00K | ▲ -12.00K | ▲ 39.00K | ▼ -129.00K | ▲ 0.00 | 0.00 |
Free Cash Flow | -15.92M | ▼ -17.50M | ▲ -16.40M | ▼ -27.31M | ▲ 44.35M | ▼ -17.49M | ▲ 5.94M |
Link | View | View | View | View | View | View | View |
Final Link | View | View | View | View | View | View | View |
Generating AI Summary...
(This could take up to 5 minutes)